JPH11508894A - Ace阻害剤とaii拮抗薬を用いる腎疾患の治療方法 - Google Patents

Ace阻害剤とaii拮抗薬を用いる腎疾患の治療方法

Info

Publication number
JPH11508894A
JPH11508894A JP9505200A JP50520097A JPH11508894A JP H11508894 A JPH11508894 A JP H11508894A JP 9505200 A JP9505200 A JP 9505200A JP 50520097 A JP50520097 A JP 50520097A JP H11508894 A JPH11508894 A JP H11508894A
Authority
JP
Japan
Prior art keywords
receptor antagonist
use according
ace inhibitor
aii receptor
aii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9505200A
Other languages
English (en)
Japanese (ja)
Inventor
レムツツイ,ジユセツペ
アイデロス,ロナルド・エス
オウエン,ロジヤー・エイ
シヤヒンフアー,シヤーナズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602854.3A external-priority patent/GB9602854D0/en
Application filed by Individual filed Critical Individual
Publication of JPH11508894A publication Critical patent/JPH11508894A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP9505200A 1995-06-30 1996-06-26 Ace阻害剤とaii拮抗薬を用いる腎疾患の治療方法 Pending JPH11508894A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77095P 1995-06-30 1995-06-30
GBGB9602854.3A GB9602854D0 (en) 1996-02-13 1996-02-13 Method of treating renal disease using an ace inhibitor and an II antagonist
GB60/000,770 1996-02-13
GB9602854.3 1996-02-13
PCT/US1996/010942 WO1997002032A1 (en) 1995-06-30 1996-06-26 Method of treating renal disease using an ace inhibitor and an aii antagonist

Publications (1)

Publication Number Publication Date
JPH11508894A true JPH11508894A (ja) 1999-08-03

Family

ID=26308665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9505200A Pending JPH11508894A (ja) 1995-06-30 1996-06-26 Ace阻害剤とaii拮抗薬を用いる腎疾患の治療方法

Country Status (5)

Country Link
EP (1) EP0835106A4 (de)
JP (1) JPH11508894A (de)
AU (1) AU716519B2 (de)
CA (1) CA2224451A1 (de)
WO (1) WO1997002032A1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003231636A (ja) * 2001-12-03 2003-08-19 Takeda Chem Ind Ltd インスリン抵抗性改善剤
JP2005533815A (ja) * 2002-06-28 2005-11-10 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ネフロパシーの処置におけるバソペプチダーゼ阻害剤の使用
JPWO2004098611A1 (ja) * 2003-05-09 2006-07-13 東レ株式会社 増強剤
JP2015507636A (ja) * 2012-01-06 2015-03-12 スピニフェクス ファーマシューティカルズ ピーティーワイ リミテッド 複素環式化合物およびその使用方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914158B2 (de) * 1996-04-05 2006-01-25 Takeda Chemical Industries, Ltd. Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin-sensitivität erhöht
WO2001060362A1 (fr) * 2000-02-18 2001-08-23 Takeda Chemical Industries, Ltd. INHIBITEURS DE TNF-$g(a)
CN1440283A (zh) * 2000-04-12 2003-09-03 诺瓦提斯公司 有机化合物的联合形式
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
HRP20030124A2 (en) * 2000-08-22 2005-02-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
DK1420774T3 (da) * 2001-08-31 2008-11-24 Australian Biomedical Company Fremstilling og diabetisk anvendelse af gibberelliner
JP2005508358A (ja) 2001-10-25 2005-03-31 デポメド・インコーポレイテッド 胃滞留型ロサルタン投与量を用いる治療方法
EP1452176A4 (de) * 2001-12-03 2009-01-21 Takeda Pharmaceutical Mittel zur verbesserung der insulinresistenz
TR201004754A1 (tr) * 2010-06-11 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Yeni Farmasötik Kombinasyonlar
CN116637115A (zh) * 2017-05-27 2023-08-25 广州喜鹊医药有限公司 川芎嗪硝酮衍生物组合物在预防和治疗糖尿病并发症疾病中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238924A (en) * 1984-05-03 1993-08-24 Merck & Co., Inc. Treatment of renal diseases with ace inhibitors
US5210079A (en) * 1988-01-07 1993-05-11 E. I. Du Pont De Nemours And Company Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
DK0527879T3 (da) * 1990-05-11 1997-07-14 Pfizer Synergistiske terapeutiske præparater og fremgangsmåder.
KR100222252B1 (ko) * 1990-12-14 1999-10-01 스튜어트 알. 수터 안지오텐신 ii 수용체 차단 조성물
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
CA2079982A1 (en) * 1991-10-07 1993-04-08 Stephen E. De Laszlo Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists
US5376666A (en) * 1992-11-30 1994-12-27 The Du Pont Merck Pharmaceutical Company Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl
EP0629408A1 (de) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Kombination von Angiotensin-Converting-Enzyme Hemmern mit A-II-Antagonisten
CZ313897A3 (cs) * 1995-04-07 1998-01-14 Novartis Ag Farmaceutické kompozice obsahující benazepril nebo benazeprilát a valsartan
EP0914158B2 (de) * 1996-04-05 2006-01-25 Takeda Chemical Industries, Ltd. Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin-sensitivität erhöht

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003231636A (ja) * 2001-12-03 2003-08-19 Takeda Chem Ind Ltd インスリン抵抗性改善剤
JP2005533815A (ja) * 2002-06-28 2005-11-10 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ネフロパシーの処置におけるバソペプチダーゼ阻害剤の使用
JPWO2004098611A1 (ja) * 2003-05-09 2006-07-13 東レ株式会社 増強剤
JP4702054B2 (ja) * 2003-05-09 2011-06-15 東レ株式会社 増強剤
JP2015507636A (ja) * 2012-01-06 2015-03-12 スピニフェクス ファーマシューティカルズ ピーティーワイ リミテッド 複素環式化合物およびその使用方法

Also Published As

Publication number Publication date
AU6291696A (en) 1997-02-05
EP0835106A1 (de) 1998-04-15
CA2224451A1 (en) 1997-01-23
AU716519B2 (en) 2000-02-24
EP0835106A4 (de) 1998-09-30
WO1997002032A1 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
Yu et al. Combining TGF-β inhibition and angiotensin II blockade results in enhanced antifibrotic effect
ES2565519T3 (es) Antagonista del receptor de angiotensina II para el tratamiento de la enfermedad cardiovascular en gatos
JP4173098B2 (ja) キマーゼ阻害剤及びace阻害剤を有効成分として含有する薬剤
JPH11508894A (ja) Ace阻害剤とaii拮抗薬を用いる腎疾患の治療方法
JP5968927B2 (ja) 高血圧と代謝症候群の治療に用いられる薬物組成物及びその応用
Zhang et al. Management of hypertension using olmesartan alone or in combination
FR2917975A1 (fr) Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
Melian et al. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension
KR100865059B1 (ko) 단순망막증 또는 전증식망막증의 예방제/치료제/진전억제제
ES2287689T3 (es) Combinacion farmaceutica para la prevencion o terapia de enfermedades cardiovasculares, cardiopulmonares, pulmonares o renales.
AU2002350832B2 (en) Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
WO2002026231A1 (en) Use of nitroxides for the treatment of vascular disorders in a diabetic mammal
JPWO2006118212A1 (ja) 膵炎の予防および治療剤
CN104324377B (zh) 一种复方降压制剂及其应用
ES2636943T3 (es) Beraprost y un inhibidor del sistema renina-angiotensina para usar en el tratamiento de enfermedades renales
JP4276768B2 (ja) 単純網膜症・前増殖網膜症の予防・治療・進展抑制剤
EP1115399B1 (de) Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephriten
EP3897633A1 (de) Verwendung eines par-1-antagonisten zur behandlung einer chronischen entzündlichen darmerkrankung
TW202310839A (zh) 用於預防或治療纖維化之醫藥組成物
HRP20030124A2 (en) Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
CN110772523A (zh) 一种用于防治肾病的药物组合物
CN119255805A (zh) 用于治疗高血压的阿普昔腾坦
KR20230006884A (ko) 뇌 아미노펩티다제 a 억제제, 이뇨제, 및 전신 레닌-안지오텐신 시스템의 차단제를 포함하는 약학 병용물
JP2007314568A (ja) チオベンズイミダゾール誘導体
JP2008538372A (ja) テトラヒドロビオプテリンおよび他の化合物を含んでなる組み合わせ製品